...
机译:间质肺病患者的肺炎球菌疫苗的反应:全身免疫抑制治疗的影响
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine;
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine;
SANWA Clinic;
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine;
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine;
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine;
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine;
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine;
Department of Microbiology Sapporo Medical University School of Medicine;
Department of Microbiology Sapporo Medical University School of Medicine;
Department of Respiratory Medicine and Allergology Sapporo Medical University School of Medicine;
Pneumococcal vaccine; Interstitial lung diseases; Idiopathic pulmonary fibrosis; Immunosuppressive;
机译:间质肺病患者的肺炎球菌疫苗的反应:全身免疫抑制治疗的影响
机译:慢性阻塞性肺疾病对肺炎球菌疫苗的反应-正在进行的全身性类固醇治疗的效果
机译:接受针对全身性硬化症相关性间质性肺疾病的免疫抑制治疗的患者血浆CXCL4水平的变化与肺功能的改善相关
机译:肺炎球菌蛋白,可构成肺炎球菌病的下一代疫苗
机译:肺炎球菌结合疫苗十三价对减少侵袭性肺炎球菌疾病的影响。
机译:接受针对全身性硬化症相关性间质性肺疾病的免疫抑制治疗的患者血浆CXCL4水平的变化与肺功能的改善相关
机译:疾病频率,患者特征,合并症结果和免疫抑制治疗系统硬化和系统性硬化相关性间质性肺病:美国队列研究
机译:基于生物标志物的系统性硬化相关间质性肺病治疗反应预测模型。